Nivolumab and Stereotactic Ablative Radiation Therapy (SAbR) for Metastatic Clear Cell Renal Cell Carcinoma
Clinical trial NCT02781506 · TERMINATED
Trial details
- NCT number
- NCT02781506
- Sponsor
- University of Texas Southwestern Medical Center
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2016-06-20
- Primary completion
- 2021-05-24
- Enrollment
- 7
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.